cinacalcet has been researched along with Hyperplasia in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (50.00) | 29.6817 |
| 2010's | 9 (45.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hur, C; Kuo, JH; Lee, JA; McManus, C; Oh, A | 1 |
| Bossola, M; Vulpio, C | 1 |
| Matuszkiewicz-Rowińska, J; Staszków, M; Wojtaszek, E; Żebrowski, P | 1 |
| Dochez, V; Ducarme, G | 1 |
| Hasegawa, T; Hosoya, T; Nakano, H; Nakayama, M; Okazaki, M; Takeguchi, F; Terawaki, H | 1 |
| Fukagawa, M; Komaba, H | 1 |
| Barsotti, G; Meola, M; Petrucci, I | 1 |
| Cattley, R; Davis, J; Henley, C; Lane, N; Li, X; Martin, D; Miller, G; Shalhoub, V; Shatzen, E; Yao, W | 1 |
| Hirai, T; Nakashima, A; Takasugi, N; Yorioka, N | 1 |
| Inoshita, N; Marui, Y; Nakamura, M; Ohashi, K; Sumida, K; Takaichi, K; Tanaka, K; Tomikawa, S; Ubara, Y | 1 |
| Goto, N; Hiramitsu, T; Izumi, K; Nanmoku, K; Nobata, H; Okada, M; Tominaga, Y; Tsujita, M; Uchida, K; Watarai, T; Yamamoto, T | 1 |
| Barsotti, G; Colombini, E; Meola, M; Petrucci, I | 1 |
| Hatamura, I; Kusano, E; Mato, M; Nakazawa, E; Ogura, M; Onishi, A; Saji, F; Shiizaki, K; Watanabe, Y | 1 |
| Colloton, M; Davis, J; Henley, CM; Martin, D; Miller, G; Shatzen, E | 1 |
| Cunningham, J; Fan, SL; Steddon, SJ | 1 |
| Colloton, M; Lacey, D; Martin, D; Miller, G; Shatzen, E; Stehman-Breen, C; Wada, M | 1 |
| de Vernejoul, MC; Legoupil, N; Ureña, P | 1 |
| Fukagawa, M; Taniguchi, M | 1 |
| Basile, C; Bruno, A; Cazzato, F; Chimienti, D; Cocola, S; Lomonte, C; Teutonico, A; Vernaglione, L | 1 |
| de Francisco, AL | 1 |
5 review(s) available for cinacalcet and Hyperplasia
| Article | Year |
|---|---|
Parathyroid Nodular Hyperplasia and Responsiveness to Drug Therapy in Renal Secondary Hyperparathyroidism: An Open Question.
Topics: Calcimimetic Agents; Calcitriol; Calcium Channel Agonists; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Hyperplasia; Parathyroid Glands; Treatment Outcome | 2018 |
Primary hyperparathyroidism during pregnancy.
Topics: Calcitonin; Cinacalcet; Female; Humans; Hypercalcemia; Hyperparathyroidism, Primary; Hyperplasia; Naphthalenes; Parathyroid Neoplasms; Pregnancy; Pregnancy Complications | 2015 |
New prospects for the management of renal bone disease.
Topics: Animals; Bone Remodeling; Calcium; Carrier Proteins; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Humans; Hyperparathyroidism; Hyperplasia; Membrane Glycoproteins; Naphthalenes; Osteoclasts; Parathyroid Glands; Parathyroid Hormone; Parathyroidectomy; Radiography; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Vitamin D | 2005 |
[Calcimimetics, mechanisms of action and therapeutic applications].
Topics: Aniline Compounds; Animals; Bone Remodeling; Calcium; Cells, Cultured; Cinacalcet; Double-Blind Method; Female; Humans; Hyperparathyroidism; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Hyperplasia; Male; Middle Aged; Multicenter Studies as Topic; Naphthalenes; Parathyroid Glands; Parathyroid Hormone; Parathyroid Neoplasms; Phenethylamines; Propylamines; Randomized Controlled Trials as Topic; Rats; Receptors, Calcium-Sensing; Renal Dialysis; Risk Factors; Time Factors; Uremia | 2005 |
New strategies for the treatment of hyperparathyroidism incorporating calcimimetics.
Topics: Animals; Calcium; Cinacalcet; Controlled Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Hyperparathyroidism, Primary; Hyperparathyroidism, Secondary; Hyperplasia; Kidney Transplantation; Naphthalenes; Parathyroid Glands; Parathyroid Hormone; Renal Insufficiency | 2008 |
2 trial(s) available for cinacalcet and Hyperplasia
| Article | Year |
|---|---|
Long-term treatment with cinacalcet and conventional therapy reduces parathyroid hyperplasia in severe secondary hyperparathyroidism.
Topics: Adult; Aged; Cinacalcet; Cohort Studies; Drug Administration Schedule; Female; Humans; Hyperparathyroidism, Secondary; Hyperplasia; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Glands; Receptors, Calcium-Sensing; Renal Dialysis; Ultrasonography, Doppler, Color | 2009 |
Association of nodular hyperplasia with resistance to cinacalcet therapy for secondary hyperparathyroidism in hemodialysis patients.
Topics: Aged; Cinacalcet; Drug Resistance; Female; Humans; Hyperparathyroidism, Secondary; Hyperplasia; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Parathyroid Glands; Prospective Studies; Renal Dialysis; Ultrasonography | 2010 |
13 other study(ies) available for cinacalcet and Hyperplasia
| Article | Year |
|---|---|
Timing of parathyroidectomy for tertiary hyperparathyroidism with end-stage renal disease: A cost-effectiveness analysis.
Topics: Calcimimetic Agents; Calcium; Cinacalcet; Computer Simulation; Cost-Benefit Analysis; Disease Progression; Humans; Hyperparathyroidism, Secondary; Hyperplasia; Kidney Failure, Chronic; Medicare; Middle Aged; Parathyroid Glands; Parathyroid Hormone; Parathyroidectomy; Quality-Adjusted Life Years; Renal Dialysis; Renal Elimination; Time-to-Treatment; United States | 2021 |
Massive soft tissue calcifications in severe hyperparathyroidism secondary to end-stage renal disease.
Topics: Arthralgia; Calcinosis; Cinacalcet; Female; Hip; Humans; Hyperparathyroidism, Secondary; Hyperplasia; Joint Diseases; Kidney Failure, Chronic; Middle Aged; Naphthalenes; Palpation; Parathyroidectomy; Radiography; Recurrence; Shoulder | 2013 |
Regression of parathyroid gland swelling by treatment with cinacalcet.
Topics: Calcium; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Hyperplasia; Kidney Failure, Chronic; Middle Aged; Naphthalenes; Parathyroid Glands; Renal Dialysis | 2009 |
Regression of parathyroid hyperplasia by calcimimetics--fact or illusion?
Topics: Calcitriol; Chronic Disease; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Hyperplasia; Kidney Diseases; Naphthalenes | 2009 |
The calcimimetic AMG 641 abrogates parathyroid hyperplasia, bone and vascular calcification abnormalities in uremic rats.
Topics: Adenine; Animals; Biomimetic Materials; Biphenyl Compounds; Bone and Bones; Calcinosis; Calcium; Cinacalcet; Dose-Response Relationship, Drug; Hyperplasia; Male; Molecular Weight; Naphthalenes; Organ Size; Parathyroid Glands; Parathyroid Hormone; Phenethylamines; Rats; Rats, Sprague-Dawley; Uremia | 2009 |
Histopathological alterations of the parathyroid glands in haemodialysis patients with secondary hyperparathyroidism refractory to cinacalcet hydrochloride.
Topics: Cell Count; Cinacalcet; Drug Resistance; Female; Humans; Hyperparathyroidism, Secondary; Hyperplasia; Kidney Failure, Chronic; Male; Middle Aged; Naphthalenes; Organ Size; Oxyphil Cells; Parathyroid Glands; Renal Dialysis | 2011 |
Tertiary hyperparathyroidism resistant to cinacalcet treatment.
Topics: Adult; Chronic Disease; Cinacalcet; Creatinine; Drug Resistance; Female; Humans; Hyperparathyroidism, Secondary; Hyperplasia; Kidney Diseases; Middle Aged; Naphthalenes; Parathyroid Glands; Parathyroidectomy; Treatment Outcome; Ultrasonography | 2011 |
Use of ultrasound to assess the response to therapy for secondary hyperparathyroidism.
Topics: Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Hyperplasia; Middle Aged; Naphthalenes; Parathyroid Glands; Parathyroid Hormone; Renal Dialysis; Treatment Outcome; Ultrasonography, Doppler, Color | 2011 |
Development and prevention of morphologic and ultrastructural changes in uremia-induced hyperplastic parathyroid gland.
Topics: Animals; Calcitriol; Capillaries; Cinacalcet; Disease Models, Animal; Hyperparathyroidism, Secondary; Hyperplasia; Male; Naphthalenes; Nephrectomy; Organelles; Parathyroid Glands; Phosphorus; Phosphorus, Dietary; Rats; Rats, Sprague-Dawley; Uremia | 2011 |
Cinacalcet HCl prevents development of parathyroid gland hyperplasia and reverses established parathyroid gland hyperplasia in a rodent model of CKD.
Topics: Animals; Calcium; Cell Proliferation; Cinacalcet; Cyclin-Dependent Kinase Inhibitor p21; Disease Models, Animal; Hyperparathyroidism, Secondary; Hyperplasia; Kidney Failure, Chronic; Male; Naphthalenes; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Rats; Rats, Sprague-Dawley; Uremia | 2012 |
Cinacalcet HCl attenuates parathyroid hyperplasia in a rat model of secondary hyperparathyroidism.
Topics: Animals; Apoptosis; Calcium; Cinacalcet; Hyperparathyroidism, Secondary; Hyperplasia; Male; Naphthalenes; Parathyroid Glands; Parathyroid Hormone; Rats; Rats, Sprague-Dawley | 2005 |
Can calcimimetics inhibit nodular hyperplasia of parathyroid glands?
Topics: Cinacalcet; Humans; Hyperplasia; Naphthalenes; Parathyroid Diseases; Parathyroid Glands | 2008 |
Does vitamin D receptor and calcium receptor activation therapy play a role in the histopathologic alterations of parathyroid glands in refractory uremic hyperparathyroidism?
Topics: Adult; Aged; Body Mass Index; Calcitriol; Cinacalcet; Drug Therapy, Combination; Female; Humans; Hyperparathyroidism, Secondary; Hyperplasia; Logistic Models; Male; Middle Aged; Naphthalenes; Oxyphil Cells; Parathyroid Glands; Parathyroidectomy; Phosphates; Receptors, Calcitriol; Receptors, Calcium-Sensing; Renal Dialysis; Risk Assessment; Risk Factors; Sex Factors; Treatment Failure; Uremia; Vitamins | 2008 |